Access to High-Cost Medicines in Australia

Agnes Isabelle Vitry, Russell Shute

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This chapter presents an overview of access pathways to high-cost medicines in Australia, including funding and pricing processes for medicines subsidised by the national pharmaceutical insurance system, the Pharmaceutical Benefits Scheme (PBS) as well as other avenues for accessing non-PBS-funded medicines. It describes current and emerging policies for facilitating access to high-cost medicines by providing better information of the public and improving engagement in decision-making.

Original languageEnglish
Title of host publicationEquitable Access to High-Cost Pharmaceuticals
PublisherElsevier
Pages165-181
Number of pages17
ISBN (Electronic)9780128119624
ISBN (Print)9780128119457
DOIs
Publication statusPublished - 21 Feb 2018
Externally publishedYes

Keywords

  • Coverage with evidence
  • Funding of medicines
  • High cost medicines
  • Pricing of medicines
  • Public pharmaceutical insurance scheme

ASJC Scopus subject areas

  • Economics, Econometrics and Finance(all)
  • Business, Management and Accounting(all)

Cite this